Researchers have genetically modified cells to produce a protein that plays a key role in embryonic kidney development and kidney regeneration after injury.
Better kidney treatment is needed due to rising incidences of diabetes and an aging population.
Although this treatment has only been performed on rats so far, the benefits could be far reaching for thousands of people on kidney transplant waiting lists.
Read more at Indiana University